Early-Stage Life Sciences

Accelerating Innovations

Connecting Science with Medical Need

About Us

Founded in 2021

PhiFund focuses on creating and supporting companies that can transform healthcare. We identify academic intellectual property and early stage companies that have the potential to greatly accelerate advances in diagnosis and treatment.

Our Values

Our values center on people, teamwork, ideas and platform technologies. Bold ambition and audacious humillity.

Our Mission

We create and nurture companies through synergies linking scientists, physicians, regulatory and business expertise.

Team

Orrin Devinsky, MD

Orrin Devinsky, MD

Managing Partner
Michael Jasulavic

Michael Jasulavic

Partner
Patricia Tolete

Patricia Tolete

Director of Operations
Megan McGill, MD, PhD

Megan McGill, MD, PhD

Entrepreneur in Residence

Portfolio

Ajna BioSciences
+
AutonomUS Medical Technologies Inc.
+
Blackrock Neurotech
+
Cirsium Biosciences
+
ConnectRN
+
Epitor Therapeutics
+
HitchBio
+
Leal Therapeutics
+
Regel Therapeutics
+
SciRhom
+
Script Bioscience
+
Somnum Pharma
+
Switch Therapeutics
+
Tevard Bioscience
+
Ajna BioSciences
+
AutonomUS Medical Technologies Inc.
+
Blackrock Neurotech
+
Cirsium Biosciences
+
ConnectRN
+
Epitor Therapeutics
+
HitchBio
+
Leal Therapeutics
+
Regel Therapeutics
+
SciRhom
+
Script Bioscience
+
Somnum Pharma
+
Switch Therapeutics
+
Tevard Bioscience
+